Coronary heart disease risk in patients with stroke or transient ischemic attack and no known coronary heart disease: findings from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.

Coronary heart disease risk in patients with stroke or transient ischemic attack and no known coronary heart disease: findings from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2010 Mar; 41(3):426-30.

View in: PubMed

subject areas

Cholesterol
Coronary Disease
Double-Blind Method
Female
Follow-Up Studies
Heptanoic Acids
Humans
Ischemic Attack, Transient
Male
Pyrroles
Stroke

authors with profiles

Larry Goldstein